{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-022945","form_type":"8-K","ticker":"SIGY","cik":"0001642159","company_name":"Sigyn Therapeutics, Inc.","filed_at":"2024-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.388328+00:00","generated_at":"2026-06-01T05:55:14.566536+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Sigyn Therapeutics reports conversion of $226,903 in debentures at $6.00 per share, issuing 37,820 shares.","bullets":["Holders converted $226,903 of Original Issue Discount Senior Convertible Debentures at avg. exercise price of $6.00/share.","Company issued 37,820 shares of common stock to debenture holders.","Outstanding common shares increased from 1,225,833 to 1,263,653 as a result.","Conversions occurred from May 30 to June 6, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-022945","json":"https://secwatch.observer/filing/0001493152-24-022945.json","markdown":"https://secwatch.observer/filing/0001493152-24-022945.md","text":"https://secwatch.observer/filing/0001493152-24-022945.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642159/000149315224022945/0001493152-24-022945-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642159/000149315224022945/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:55:14.566536+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}